Cresset Asset Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.33M | Sell |
12,818
-1,897
| -13% | -$169K | ﹤0.01% | 797 |
|
|
2026
Q1 | $1.06M | Sell |
14,715
-1,996
| -12% | -$154K | ﹤0.01% | 763 |
|
|
2025
Q4 | $1.33M | Buy |
16,711
+713
| +4% | +$56.2K | 0.01% | 686 |
|
|
2025
Q3 | $1.21M | Buy |
15,998
+845
| +6% | +$57.9K | 0.01% | 678 |
|
|
2025
Q2 | $1.05M | Sell |
15,153
-5,898
| -28% | -$387K | 0.01% | 675 |
|
|
2025
Q1 | $1.43M | Sell |
21,051
-4,379
| -17% | -$262K | 0.01% | 649 |
|
|
2024
Q4 | $1.14M | Sell |
25,430
-152,584
| -86% | -$8.56M | 0.01% | 745 |
|
|
2024
Q3 | $11.2M | Sell |
178,014
-13,889
| -7% | -$810K | 0.04% | 279 |
|
|
2024
Q2 | $11.3M | Sell |
191,903
-14,973
| -7% | -$937K | 0.05% | 254 |
|
|
2024
Q1 | $16.5M | Buy |
206,876
+29,075
| +16% | +$2.22M | 0.08% | 170 |
|
|
2023
Q4 | $14M | Sell |
177,801
-15,471
| -8% | -$1.1M | 0.08% | 163 |
|
|
2023
Q3 | $13.5M | Buy |
193,272
+10,241
| +6% | +$726K | 0.05% | 171 |
|
|
2023
Q2 | $12.7M | Buy |
183,031
+135,222
| +283% | +$9.62M | 0.02% | 233 |
|
|
2023
Q1 | $3.55M | Sell |
47,809
-1,968
| -4% | -$165K | 0.07% | 156 |
|
|
2022
Q4 | $3.8M | Sell |
49,777
-2,579
| -5% | -$249K | 0.05% | 144 |
|
|
2022
Q3 | $4.99M | Buy |
52,356
+398
| +0.8% | +$39.4K | 0.06% | 126 |
|
|
2022
Q2 | $4.81M | Buy |
51,958
+1,047
| +2% | +$102K | 0.06% | 132 |
|
|
2022
Q1 | $5.15M | Sell |
50,911
-5,598
| -10% | -$588K | 0.05% | 124 |
|
|
2021
Q4 | $5.83M | Buy |
56,509
+758
| +1% | +$70K | 0.06% | 132 |
|
|
2021
Q3 | $4.73M | Buy |
55,751
+10,256
| +23% | +$859K | 0.06% | 119 |
|
|
2021
Q2 | $3.8M | Buy |
45,495
+23,489
| +107% | +$1.92M | 0.05% | 138 |
|
|
2021
Q1 | $1.66M | Sell |
22,006
-13,464
| -38% | -$981K | 0.03% | 199 |
|
|
2020
Q4 | $2.42M | Sell |
35,470
-3,387
| -9% | -$220K | 0.04% | 139 |
|
|
2020
Q3 | $2.27M | Buy |
38,857
+1,062
| +3% | +$66.1K | 0.04% | 148 |
|
|
2020
Q2 | $2.46M | Buy |
37,795
+18,775
| +99% | +$1.18M | 0.05% | 127 |
|
|
2020
Q1 | $1.13M | Buy |
19,020
+1,648
| +9% | +$110K | 0.03% | 178 |
|
|
2019
Q4 | $1.29M | Buy |
17,372
+10,459
| +151% | +$734K | 0.03% | 178 |
|
|
2019
Q3 | $436K | Buy |
6,913
+677
| +11% | +$40.1K | 0.01% | 290 |
|
|
2019
Q2 | $340K | Buy |
6,236
+285
| +5% | +$15.3K | 0.01% | 317 |
|
|
2019
Q1 | $321K | Sell |
5,951
-225
| -4% | -$13.9K | 0.01% | 251 |
|
|
2018
Q4 | $405K | Buy |
+6,176
| New | +$461K | 0.02% | 139 |
|
Other funds holding CVS
Cresset Asset Management's CVS Position: Q2 2026 in Review
Cresset Asset Management reduced its CVS Health (CVS) stake by 13% in Q2 2026, selling an estimated $169K and leaving 12,818 shares worth $1.33M. The position accounts for ﹤0.01% of the portfolio, ranked #797.
Cresset Asset Management first reported a position in CVS in Q4 2018 and has held it in 31 quarters since. The position peaked at $16.5M in Q1 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Cresset Asset Management held 12,818 shares of CVS Health worth $1.33M as of Q2 2026.
- Cresset Asset Management sold 1,897 CVS Health shares in Q2 2026, an estimated $169K.
- CVS Health made up ﹤0.01% of Cresset Asset Management's portfolio in Q2 2026, its #797 holding.
- Cresset Asset Management first reported a position in CVS Health in Q4 2018 and has held it in 31 quarters since.
- Cresset Asset Management's CVS Health position peaked at $16.5M in Q1 2024.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.